The Uromigos Episode 3: Pembrolizumab in Non-Muscle Invasive Bladder Cancer

Guests Dr. Arjun Balar, associate professor of medicine at NYU and director of the GU program at the Perlmutter Cancer Center, and Dr. Seth Lerner, professor of urology and director of urologic oncology in the bladder cancer program at Baylor College of Medicine, give an overview of the FDA approval of pembrolizumab in this indication to Professor Tom Powles and Dr. Brian Rini.

They also discuss data from the KEYNOTE-057 study, for which Dr. Balar was the lead investigator, and the emerging opportunities for immunotherapy in non-muscle invasive bladder cancer.